eIF3e-mediated translational checkpoint maintains immune tolerance and prevents lymphoid malignancy

Read full text
Authors: Lianghua Lin, Pengda Chen, Yi-Xiang Wang, Chao Huang, Xinyong Lin, Chang Liu, Kunyu Liao, Jianfeng Wu, Amy Chadburn, Y Zhang, Huilin Song, Chenxi Wang
+11 more Zhichen Wan, Jiayi Zhao, Guangyi Cao, Xinming Wang, Liang Yang, Nan Yao, Yazhen Hong, Zhengtao Xiao, Dieter A Wolf, Wen‐Hsien Liu, Changchun Xiao
Cited by: 1
References: 63

Abstract

Translational control is essential for immune function, but its roles in immune tolerance and lymphomagenesis remain poorly defined. Here, we show that Cγ1Cre-mediated deletion of Eif3e, which encodes a subunit of the eIF3 translation initiation complex, in B cells causes lymphoproliferation, malignant transformation of Eif3e-sufficient bystander lymphocytes, and premature death. Eif3e-deficient B cells upregulate the costimulatory molecule CD80, promoting CD4+ T cell activation and differentiation into IL-4-producing TFH-like cells. These cells, in turn, activate bystander B cells, increase MHC class II expression, and establish a feedforward loop of Eif3e deletion and lymphocyte activation. Despite their hyperactivated state, Eif3e-deficient B cells exhibit impaired proliferation, reduced survival, and defective differentiation. This self-amplifying circuit of aberrant B and T cell activation ultimately drives malignant transformation of Eif3e-sufficient lymphocytes. Our findings uncover an eIF3e-dependent translational checkpoint that preserves immune homeostasis and restrains lymphomagenesis.

Fields of Study & Subjects

Endoplasmic Reticulum Stress and Disease PI3K/AKT/mTOR signaling in cancer RNA regulation and disease

Publication details

Journal / source
The Journal of Experimental Medicine
Publisher
Rockefeller University Press
Volume
223
Issue
8
Publication date
14 May 2026
Language
EN